Product Images Salicor

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Salicor NDC 83881-421 by Clinic Pharma, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Back Label - Salicor Carton Back 082725

Back Label - Salicor Carton Back 082725

This text contains information about a drug patch with Triethanolamine Salicylate 10% as the active ingredient for temporary pain relief. It provides warnings regarding usage, including restrictions on application areas and frequency. The directions for use include steps for applying and disposing of the patch properly. It also mentions precautions for pregnant or breastfeeding individuals and the need to seek medical help in case of ingestion. The patch is intended for adults over 18 years old. Inactive ingredients include Crospovidone and polyisobutylene rubber PSA adhesive. For any questions, a toll-free number is provided.*

Front - Salicor Front 061025

Front - Salicor Front 061025

This text provides information about a product with NDC code 83881-421-15 called "Salicer." It contains Triethanolamine Salicylate at a concentration of 10%. The product is designed for active wear with fast-acting properties, all-night hold, and water resistance. It includes 15 patches measuring 2.47 x 8.5 inches (6cm x 9.5 cm) and is dispensed by prescription.*

Back PPI - Salicor Package Insert Back 061825

Back PPI - Salicor Package Insert Back 061825

The text provides information about Salicorâ„¢, a product used for external pain relief. It warns of the risk of developing methemoglobinemia, a serious condition, and lists signs to watch for. It discusses drug interactions and cautions, especially with antiarrhythmic drugs and local anesthetics. The text covers potential effects on fertility, pregnancy, labor, delivery, nursing mothers, and pediatric use. It highlights drugs that can cause methemoglobinemia when used with Salicorâ„¢. Additionally, it describes adverse reactions, serious adverse events, overdose symptoms, and how to manage them, mentions dosage and administration instructions, as well as handling and disposal guidelines. Storage instructions, supply details, and contact information for Clinic Pharma are also included.*

PPI FRONT - Salicor Package Insert Front 061825

PPI FRONT - Salicor Package Insert Front 061825

Salicorâ„¢ is an external analgesic product containing 10% triethanolamine salicylate, designed for temporary relief of minor pain associated with arthritis, backache, muscle strains, sprains, and bruises. It inhibits COX enzymes involved in inflammation and pain generation, acts similarly to topical NSAIDs, and is well-tolerated with low systemic absorption. This patch formulation offers convenience and sustained relief directly at the site of pain. It is contraindicated in patients allergic to salicylates or aspirin and should not be swallowed or applied to damaged skin. Caution is advised for patients with GI ulcers, hepatic disease, or allergies, and it should not be used with external heat sources. If allergic reactions or complications arise, discontinue use and seek medical attention.*

Visual Guide - image (50)

Visual Guide - image (50)

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.